Geode Capital Management, LLC Omeros Corp Transaction History

Geode Capital Management, LLC

  • $1.12 Trillion
  • Q2 2024

A detailed history of Geode Capital Management, LLC transactions in Omeros Corp stock. As of the latest transaction made, Geode Capital Management, LLC holds 1,332,412 shares of OMER stock, worth $5.66 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,332,412
Previous 1,378,077 3.31%
Holding current value
$5.66 Million
Previous $4.75 Million 13.78%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024
SELL
$3.04 - $4.23 $138,821 - $193,162
-45,665 Reduced 3.31%
1,332,412 $5.41 Million
Q1 2024

May 13, 2024
BUY
$2.88 - $4.89 $113,368 - $192,489
39,364 Added 2.94%
1,378,077 $4.75 Million
Q4 2023

Feb 13, 2024
BUY
$1.08 - $3.63 $60,444 - $203,160
55,967 Added 4.36%
1,338,713 $4.38 Million
Q3 2023

Nov 13, 2023
BUY
$2.81 - $5.69 $81,588 - $165,209
29,035 Added 2.32%
1,282,746 $3.75 Million
Q2 2023

Aug 11, 2023
BUY
$4.45 - $7.57 $2.77 Million - $4.71 Million
621,819 Added 98.41%
1,253,711 $6.82 Million
Q1 2023

May 15, 2023
BUY
$2.48 - $5.22 $64,678 - $136,137
26,080 Added 4.3%
631,892 $2.94 Million
Q4 2022

Feb 13, 2023
BUY
$1.75 - $3.96 $12,710 - $28,761
7,263 Added 1.21%
605,812 $1.37 Million
Q3 2022

Nov 14, 2022
SELL
$3.09 - $7.46 $101,713 - $245,560
-32,917 Reduced 5.21%
598,549 $1.89 Million
Q2 2022

Aug 12, 2022
SELL
$1.92 - $6.28 $918,990 - $3.01 Million
-478,641 Reduced 43.12%
631,466 $1.74 Million
Q1 2022

May 13, 2022
BUY
$5.07 - $7.2 $87,579 - $124,372
17,274 Added 1.58%
1,110,107 $6.67 Million
Q4 2021

Feb 11, 2022
BUY
$5.67 - $8.54 $155,125 - $233,645
27,359 Added 2.57%
1,092,833 $7.03 Million
Q3 2021

Nov 12, 2021
BUY
$13.4 - $16.3 $376,258 - $457,687
28,079 Added 2.71%
1,065,474 $14.7 Million
Q2 2021

Aug 13, 2021
BUY
$14.81 - $19.13 $629,128 - $812,642
42,480 Added 4.27%
1,037,395 $15.4 Million
Q1 2021

May 12, 2021
BUY
$14.52 - $23.53 $1.06 Million - $1.72 Million
73,113 Added 7.93%
994,915 $17.7 Million
Q4 2020

Feb 12, 2021
BUY
$10.14 - $15.19 $1.01 Million - $1.52 Million
99,839 Added 12.15%
921,802 $13.2 Million
Q3 2020

Nov 13, 2020
BUY
$9.57 - $21.32 $652,635 - $1.45 Million
68,196 Added 9.05%
821,963 $8.31 Million
Q2 2020

Aug 13, 2020
BUY
$12.21 - $16.99 $257,362 - $358,115
21,078 Added 2.88%
753,767 $11.1 Million
Q1 2020

May 14, 2020
BUY
$9.03 - $19.72 $467,492 - $1.02 Million
51,771 Added 7.6%
732,689 $9.8 Million
Q4 2019

Feb 13, 2020
BUY
$13.01 - $17.15 $721,235 - $950,744
55,437 Added 8.86%
680,918 $9.59 Million
Q3 2019

Nov 12, 2019
BUY
$14.55 - $20.56 $119,077 - $168,263
8,184 Added 1.33%
625,481 $10.2 Million
Q2 2019

Aug 14, 2019
BUY
$15.0 - $19.62 $720,120 - $941,916
48,008 Added 8.43%
617,297 $9.69 Million
Q1 2019

May 14, 2019
BUY
$11.65 - $17.72 $613,454 - $933,082
52,657 Added 10.19%
569,289 $9.89 Million
Q4 2018

Feb 13, 2019
BUY
$10.72 - $16.73 $385,641 - $601,845
35,974 Added 7.48%
516,632 $5.76 Million
Q3 2018

Nov 13, 2018
BUY
$17.73 - $26.69 $408,729 - $615,284
23,053 Added 5.04%
480,658 $11.7 Million
Q2 2018

Aug 14, 2018
BUY
$10.79 - $24.44 $625,820 - $1.42 Million
58,000 Added 14.51%
457,605 $8.3 Million
Q1 2018

May 15, 2018
BUY
$9.0 - $20.16 $71,604 - $160,392
7,956 Added 2.03%
399,605 $4.46 Million
Q4 2017

Feb 13, 2018
BUY
$13.26 - $22.86 $154,704 - $266,707
11,667 Added 3.07%
391,649 $7.61 Million
Q3 2017

Nov 14, 2017
BUY
$19.76 - $24.9 $703,120 - $886,016
35,583 Added 10.33%
379,982 $8.22 Million
Q2 2017

Aug 14, 2017
BUY
N/A
344,399
344,399 $6.86 Million

Others Institutions Holding OMER

# of Institutions
113
Shares Held
25.5M
Call Options Held
317K
Put Options Held
556K
View Full List

About OMEROS CORP

OMER Quotes by TradingView
  • Ticker OMER
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,730,000
  • Market Cap $267M
  • Description
  • Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...
More about OMER
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email